Načítá se...
Hydroxychloroquine in the post-COVID-19 era: will this pandemic upset decades of clinical practice?
In the early stage of the COVID-19 pandemic, Belgian health authorities endorsed the interim guidelines for the treatment of COVID-19 pneumonia: hydroxychloroquine (HCQ) recommended for treatment of hospitalized patients with moderate to severe disease. As a growing number of patients were admitted,...
Uloženo v:
| Vydáno v: | Clin Rheumatol |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer International Publishing
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7810282/ https://ncbi.nlm.nih.gov/pubmed/33452660 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10067-020-05572-9 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|